by Rumaizah | Sep 30, 2022 | Uncategorized
Originally posted on https://www.globenewswire.com/news-release/2022/09/28/2523982/0/en/Neurowyzr-and-Allium-Healthcare-Announce-a-first-of-its-kind-Partnership-for-Brain-Health-for-Active-Agers.html
- Active Agers in Singapore to access innovative and cost-effective brain health assessments and therapy
SINGAPORE, Sept. 28, 2022 (Via GLOBE NEWSWIRE) — Neurowyzr, the Singapore Deep Neuroscience and Brain Capital company with a vision to optimize population and corporate brain health and performance using neuroscience-based digital solutions, announces a partnership with Allium Healthcare to jointly develop brain health programs to help Active Agers screen, monitor, prevent and improve brain health.
Allium will be the first Intermediate and Long-Term care (ILTC) provider in Asia-Pacific to provide Active Ageing programs focused on the brain, using Neurowyzr’s Digital Brain Function Screen and future brain health solutions. For a start, Allium will provide Neurowyzr’s Digital Brain Function Screen that enables early detection of cognitive decline to its residents, day care participants, and members of the community. The digital and gamified solution only takes 14-16 mins to complete and can be completed on a phone or browser. Users will receive a report upon completion that Allium healthcare staff will discuss with their patient in-depth.
Neuroscience studies show that from the age of 30, nearly 10% of people already begin to experience a brain health problem called Mild Cognitive Impairment (MCI). The proportion increases to 25% among people aged 50, and 40% at 60 years1. As such, the World Health Organisation and leading clinical neuroscientists have recommended brain cognitive screening for all adults as part of routine healthcare screening. Early recognition can prevent and reduce the disability of brain health problems that are associated with cognitive decline, stroke, Long Covid brain damage, Parkinson’s disease and dementia. This has the potential to enable prevention, early recognition and treatment of brain health problems that affect millions of people in the Asia Pacific.
Allium will work with Neurowyzr to design therapy options for those detected to have conditions such as Mild Cognitive Decline. Studies such as the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) have shown that therapy for those at risk of cognitive decline is useful in rolling back the condition. Therapy can include computerised cognitive training, diet, aerobic exercise, strength training, improved management of vascular and metabolic conditions. Allium plans to introduce such therapy packages to Singapore, and also study its effectiveness.
Neurowyzr will also work with Allium to roll out future digital neuroscience solutions such as Digital Brain Health Diagnostics and Digital Therapy.
Bernie Poh, CEO, Allium Healthcare commented, “Allium Healthcare works with leading and innovative teams to transform our vision for the finest of hospitality and healthcare into a reality. We are constantly innovating to expand our services to the community. With Singapore’s increasing focus on preventative care, we are excited to leverage new technologies to help Singaporeans on their healthy ageing journeys. This partnership with Neurowyzr increases Allium’s capability to focus on brain health.”
Pang Sze Yunn, CEO, Neurowyzr, commented, “Our partnership with Allium enables Neurowyzr to address the problem of the early cognitive decline among the population. Not only will the population be able to access affordable cognitive screening, there will be more opportunities for them to find therapy options to reverse the decline. We are excited to work with an innovative new partner that is committed to finding solutions to a major societal problem.”
Media Contact
Adrienne Chin
adrienne@neurowyzr.com
About Neurowyzr
Neurowyzr is a Deep Neuroscience and Brain Capital company using the latest discoveries in neuroscience to optimize corporate and population brain health and performance. Built by neuroscientists and powered by advanced analytics and AI, Neurowyzr offers a digital platform and software as a service to unlock the potential of individuals and organizations. Neurowyzr has supported leading organisations in Asia in growing their brain capital to build stronger, more resilient and innovative teams. To find out more about Neurowyzr, please visit Neurowyzr.com or follow Neurowyzr on LinkedIn.
Adeline Thia
Thia.Adeline@alliumhealthcare.com
About Allium Healthcare
The Allium Healthcare model benefits from 20 years of experience as a private operator of nursing homes. In Australia, Allium Healthcare co-owns Opal HeaIthcare, one of the largest and leading specialist aged care provider with 8,000 beds in 84 facilities across four states. Allium Care Suites, Singapore’s first premium residential care home on Venus Drive, presents exclusively single and companion suites, bringing together the finest of hospitality and healthcare in skilled nursing, rehabilitative and respite care. Inspired by wellness, defined by personalised care, a team of nurses, allied health professionals and Care Concierges deliver rewarding ages care experiences across residential care, day care, home care and care support services. Discover more at alliumhealthcare.com
___________________________________
1 Eric Braverman, M.D., Cognitive Decline of Aging: Important Neuroendocrinological Predictors of Early Cognitive Decline in A Clinical Setting
by Alan Khor | May 19, 2022 | Uncategorized
- Patients in Singapore are the first in the APAC region to access rapid, fully digitised, cost-effective brain health cognitive assessments
Singapore, May 19, 2022 – Neurowyzr, the Singapore Brain Capital company with a vision to optimize population and corporate brain health and performance using neuroscience-based digital solutions, announces a partnership with Parkway Shenton to provide its patients with digital brain health screening and monitoring tools. Parkway Shenton is the first primary healthcare provider in the Asia Pacific to provide digital brain screening and monitoring using Neurowyzr’s proprietary Digital Brain Function Scan. This has the potential to enable earlier recognition of brain health problems that affect millions of people in the Asia Pacific. Early recognition can prevent and reduce the disability of brain health problems that are associated with cognitive decline, stroke, Long Covid brain damage, Parkinson’s disease and dementia.
For the first time, Singaporeans and residents have access to a digital neuroscience tool through a primary care provider that enables early detection of cognitive decline. Quick, affordable and available through an online portal after being prescribed by a physician, people no longer need to spend thousands of dollars and several days visiting a specialist clinic to understand the health of their brain.
The World Health Organisation and leading clinical neuroscientists recommend brain cognitive screening for all adults as part of routine healthcare screening. Neuroscience studies show that from the age of 30, nearly 10% of people already begin to experience a brain health problem called Mild Cognitive Impairment (MCI). The proportion increases to 25% among people aged 50, and 40% at 60 years1. People that are at higher risk of brain health problems such as MCI include those with undetected and untreated or poorly- controlled chronic Non-Communicable Diseases (NCD) such as hypertension, diabetes, obesity, metabolic syndrome, high cholesterol, and high lipids. It also includes those who appear healthy but have early liver, kidney, lung and heart failure or dysfunction. This is a major reason to include digital brain health screening as a component of general health screening. It allows users to have a comprehensive picture of their brain and body health, and enables personalised recommendations to be made.
With Neurowyzr’s medical-grade Digital Brain Function Scan that is registered with the Singapore Health Services Authority, patients use any connected device (such as a mobile phone, iPad, laptop or PC) and a browser to complete an assessment within minutes. They receive a report upon completion that the prescribing physician will discuss with their patient in-depth. The ease of the tool significantly reduces the time and dollar burden of traditional cognitive testing that is done in-person with pen and paper that can cost up to several thousand dollars and many hours of physician and patient time.
The Digital Brain Function Scan allows populations to be proactive and preventative when it comes to maintaining the health of their brains. It aims to enable early intervention for brain conditions before severe and irreversible problems arise.
Dr Edwin Chng, Medical Director, Parkway Shenton, commented, “We are constantly expanding our service offerings to patients and leveraging new technologies to bring greater convenience and quality of care to the community. This partnership with Neurowyzr gives Parkway Shenton the unique capability to promote brain health and help our patients play an active role in identifying and preventing problems with cognition.”
Pang Sze Yunn, CEO, Neurowyzr, commented, “Our partnership with Parkway Shenton is an important step in the right direction of recognizing and preventing early cognitive decline. The sooner healthcare providers can intervene when cognitive issues arise, the better the outcomes are for the population. With the increasing medical, social and economic burden of chronic Non-Communicable Diseases, governments and organisations should be paying closer attention to the brain health of citizens and employees. We are excited to work with a new partner who recognises this, and look forward to signing with other likeminded organisations in the months ahead.”
1 Eric Braverman, M.D., Cognitive Decline of Aging: Important Neuroendocrinological Predictors of Early Cognitive Decline in A Clinical Setting
Ends
Media Contact
Hannah Crowe / Jia Rong Chew
Spurwing Communications
Neurowyzr@spurwingcomms.com
About Neurowyzr
Neurowyzr is a brain capital company using the latest thinking in neuroscience to optimize employee brain health and performance. Built by neuroscientists and powered by advanced analytics and AI, Neurowyzr offers a digital platform and software as a service to unlock the potential of individuals and organizations. Neurowyzr has supported leading organisations in Asia in growing their brain capital to build stronger, more resilient and innovative teams. To find out more about Neurowyzr, please visit Neurowyzr.com or follow Neurowyzr on LinkedIn.
About Parkway Shenton
Parkway Shenton is the leading primary healthcare provider in Singapore, with a network of panel general practitioner (GP) clinics and specialists, in-house clinics at corporate clients’ premises, Executive Health Screening as well as Accident and Emergency Departments/24-hour clinics. Through its chain of facilities that are conveniently located island-wide, Parkway Shenton provides a comprehensive range of healthcare services to patients of all ages. Parkway Shenton’s large pool of family physicians are well-qualified in family medicine and management of chronic diseases to provide cost-effective and patient-centric care. It is committed to delivering quality patient care and promoting health and wellness, to help its corporate clients and the general public lead healthier, fuller lives. Parkway Shenton is part of IHH Healthcare, one of the world’s largest healthcare groups with some of the best-known providers of private healthcare in Asia including Acibadem (Turkey), Parkway Group Singapore, Gleneagles Hospitals (Singapore, India, Hong Kong, China), Mount Elizabeth hospitals (Singapore), Fortis hospitals (India), Prince Court Hospital and Pantai Hospital(Malaysia). For more information, please go to www.parkwayshenton.com.
by Alan Khor | Apr 11, 2022 | Uncategorized
Singapore, April 11, 2022 – Today, Neurowyzr, the Singapore brain capital company with a vision to optimize employee brain health and performance, announced a strategic collaboration with the Singapore National Employers Federation (SNEF) on brain capital education and consultancy services. A first in Singapore to focus on corporate brain health, the collaboration aims to empower SNEF members to grow their organisational brain capital for the benefit of their employees and organization.
Under the terms of the collaboration, Neurowyzr will provide SNEF corporate members with training programs on various topics within the sphere of workplace brain health, such as the Neuroscience of Leadership, and Brain Capital Ambassador training for managers. Neurowyzr will also work closely with SNEF on providing expert consultancy services to SNEF members to build a happy, resilient and innovative local workforce.
Stephen Yee, Deputy Executive Director of SNEF, commented, “Covid 19 has placed tremendous strain on Singapore companies and workers. We have seen how mental health issues can negatively affect employee performance. SNEF recognizes the importance of approaching brain health holistically, to cover both cognitive and mental health. We are excited to work in partnership with Neurowyzr to provide training and brain health expertise to employers. We want to help Singapore employers build long-term strategies to grow organizational brain capital so that they can innovate and thrive.”
Pang Sze Yunn, CEO, Neurowyzr, commented, “As the Singapore economy becomes more knowledge intensive and complex, there has never been a more pressing time for employers to consider how their workforce can operate at peak brain performance. By objectively measuring brain capabilities and supporting employees to enhance their brain health using a digital platform and software as a service, we will help SNEF member companies unlock individual and organization potential using neuroscience.”
Ends
Media Contact
Hannah Crowe / Jia Rong Chew
Spurwing Communications
Neurowyzr@spurwingcomms.com
About Neurowyzr
Neurowyzr is a brain capital company using the latest thinking in neuroscience to optimize employee brain health and performance. Built by neuroscientists and powered by advanced analytics and AI, Neurowyzr offers a digital platform and software as a service to unlock the potential of individuals and organizations. Neurowyzr has supported leading organisations in Asia in growing their brain capital to build stronger, more resilient and innovative teams. To find out more about Neurowyzr, please visit Neurowyzr.com or follow Neurowyzr on LinkedIn.
About SNEF
The Singapore National Employers Federation (SNEF) is a trade union of employers. Our mission is to advance tripartism and enhance labour market flexibility to enable employers to implement responsible employment practices for sustainable growth. SNEF has a membership of over 3,300 companies with a combined workforce of over 800,000. For more information, please visit www.snef.org.sg
You must be logged in to post a comment.